Translational activities
Our goal is to provide a new class of antibiotics and innovative antimicrobial strategies by targeting in vivo pathogen behaviour, providing new hope in the fight against AMR.
To facilitate the development of novel anti-infective strategies, we have already initiated collaborations with several different industry partners aiming at compound screening and optimisation, evaluation of non-conventional antimicrobials, defining novel antibiotic targets, and predicting pharmacokinetic/pharmacodynamics (PK/PD) in humans. Through these collaborations, we ensure early knowledge and technology transfer and gain in-depth insights in industrial requirements and opportunities.
Leadership of Translational Activities
![](/wp-content/uploads/2023/09/Physics-Chem_Uwe_Sauer.jpg)
Leader:
Uwe Sauer »
![](/wp-content/uploads/2023/09/Engineerng_Andreas_Hierlemann.jpg)
Co-Leader:
Andreas Hierlemann »
![antiresist](/wp-content/uploads/2023/08/crosslink-image.jpg)